Gmo Benchmark-free Valuation
| GBMBX Fund | USD 26.81 0.17 0.64% |
At this time, the entity appears to be fairly valued. Gmo Benchmark Free retains a regular Real Value of $26.91 per share. The prevalent price of the fund is $26.81. We determine the value of Gmo Benchmark Free from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.
Fairly Valued
Today
Please note that Gmo Benchmark-free's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Gmo Benchmark Free retains a regular Real Value of $26.91 per share. The prevalent price of the fund is $26.81. We determine the value of Gmo Benchmark Free from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.
Since Gmo Benchmark-free is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Gmo Mutual Fund. However, Gmo Benchmark-free's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 26.81 | Real 26.91 | Hype 26.81 | Naive 26.74 |
The intrinsic value of Gmo Benchmark-free's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Gmo Benchmark-free's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Gmo Benchmark Free Allocation helps investors to forecast how Gmo mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Gmo Benchmark-free more accurately as focusing exclusively on Gmo Benchmark-free's fundamentals will not take into account other important factors: Gmo Benchmark-free Total Value Analysis
Gmo Benchmark Free Allocation is currently forecasted to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Gmo Benchmark-free fundamentals before making investing decisions based on enterprise value of the companyGmo Benchmark-free Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Gmo suggests not a very effective usage of assets in November.About Gmo Benchmark-free Valuation
Our relative valuation model uses a comparative analysis of Gmo Benchmark-free. We calculate exposure to Gmo Benchmark-free's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Gmo Benchmark-free's related companies.The fund is structured as a fund of funds and gains its investment exposures primarily by investing in Implementation fund. In addition, the fund may invest in any other GMO fund, whether now existing or created in the future. These underlying GMO Funds may include, among others, Opportunistic Income fund, Emerging Country Debt fund, High Yield fund, and the Alternative funds. The fund is permitted to invest in any asset class, strategy, sector, country, or region, and at times may have substantial exposure to a single asset class, sector, country, region, or currency or companies with similar market capitalizations.
Other Information on Investing in Gmo Mutual Fund
Gmo Benchmark-free financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Benchmark-free security.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |